Clinical Trials
14 trialsNCT04541108 2026-05-22
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Presage Biosciences
Phase EARLY_PHASE1 Active not recruiting
NCT04480645 2026-03-24
CivaDerm(TM) Surface Therapy Pilot Study
CivaTech Oncology
Phase EARLY_PHASE1 Completed
NCT06305962 2026-02-19
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Phase EARLY_PHASE1 Recruiting
NCT05098184 2025-12-11
A Study of GC101 TIL in Advanced Melanoma (10hospital)
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1 Recruiting
NCT03893019 2024-05-16
MB-CART20.1 Melanoma
Miltenyi Biomedicine GmbH
Phase EARLY_PHASE1 Terminated
NCT05932511 2023-08-30
Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer
Center for Biomedical Research, Inc.
Phase EARLY_PHASE1 Unknown
NCT05961111 2023-07-27
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Recruiting
NCT03655756 2022-08-08
pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma
TuHURA Biosciences, Inc.
Phase EARLY_PHASE1 Completed
NCT04891718 2022-07-08
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
Presage Biosciences
Phase EARLY_PHASE1 Withdrawn
NCT04279535 2021-11-02
Topical Vitamin C for Treatment of Basal Cell Cancer
Center for Biomedical Research, Inc.
Phase EARLY_PHASE1 Completed
NCT03649529 2019-12-06
Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy
Timmune Biotech Inc.
Phase EARLY_PHASE1 Unknown
NCT03454243 2019-04-25
TITAN
Hoffmann-La Roche
Phase EARLY_PHASE1 Terminated
NCT02442466 2015-05-20
Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma
MelCure SA
Phase EARLY_PHASE1 Terminated
NCT00743353 2009-02-02
K5
Siemens Molecular Imaging
Phase EARLY_PHASE1 Completed